Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, September 16, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Interpack 2014: Sterile and Ready to Use Packaging by SCHOTT
Thursday, May 08, 2014
SCHOTT’s sterile, ready to use vials adaptiQ™ will be on display at Interpack.

Gallus BioPharmaceuticals Utilizes ambr15 Micro Bioreactor
Tuesday, May 06, 2014
To rapidly optimize process development of novel antibodies and biosimilars.

Quantitative Imaging Mode of the NanoWizard 3
Thursday, May 01, 2014
JPK Instruments reports on the use of the Quantitative Imaging mode for tissue engineering studies at Niigata University.

Top Pharma, Biotechs and CRO choose ambr250 Automated Mini Bioreactor System
Friday, April 25, 2014
To accelerate their process scale-up of biological therapies and vaccines.

Cotton Rat Influenza Model Launched by Noble Life Sciences
Wednesday, April 23, 2014
New cotton rat model for preclinical studies of influenza therapies and vaccines.

New Approach to Temperature Control in Cell Therapy Clinical Trial
Wednesday, April 23, 2014
CoolCell® cell freezing device and CoolBox™ ice-free cooling workstations chosen to support handling and processing of investigational cell therapy product in landmark clinical research trial.

Titian Software to Preview Latest Version of its Leading Sample Management Software
Wednesday, April 16, 2014
Mosaic 6.0 enhances the management of compounds, biologicals and reagents.

New Peristaltic Pump Delivers Unparalleled Flexibility in Fluid Transfer
Wednesday, April 16, 2014
Broad flow range, ergonomic, compact design easily integrates into space-constrained applications.

Efficient Delivery of Proteins into Living Cells
Tuesday, April 15, 2014
BioPORTER® protein delivery reagent from AMSBIO.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 460
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv